These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28119019)

  • 61. Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.
    Hatfaludi T; Al-Hasani K; Gong L; Boyce JD; Ford M; Wilkie IW; Quinsey N; Dunstone MA; Hoke DE; Adler B
    PLoS One; 2012; 7(7):e39973. PubMed ID: 22792202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-protection against fowl cholera disease with the use of recombinant Pasteurella multocida FHAB2 peptides vaccine.
    Tatum FM; Tabatabai LB; Briggs RE
    Avian Dis; 2012 Sep; 56(3):589-91. PubMed ID: 23050479
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.
    Lee J; Kang HE; Woo HJ
    Clin Vaccine Immunol; 2012 Sep; 19(9):1526-31. PubMed ID: 22837096
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of a subcutaneously administered, ultraviolet light-killed Pasteurella multocida A:3-containing bacterin against transthoracic challenge exposure in goats.
    Purdy CW; Straus DC; Ayers JR
    Am J Vet Res; 1997 Aug; 58(8):841-7. PubMed ID: 9256967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three novel immunogenic proteins determined through 2-Dimensional electrophoresis and mass spectrometry with immune serum confer protection against challenge with porcine Pasteurella multocida in mouse models.
    Wang F; Wang X; Ai W; Zeng D; Liang W; Hua L; Liu H; Wang X; Tian Y; Chen H; He Q; Peng Z; Wu B
    Res Vet Sci; 2021 May; 136():303-309. PubMed ID: 33744821
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Host responses and bacterial colonization following inoculation of Pasteurella multocida P
    Singh M; Verma R; Pandit RS; Tarfain NU
    Microb Pathog; 2017 Oct; 111():269-273. PubMed ID: 28888883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity of outer membrane protein of Pasteurella multocida in buffalo calves.
    Pati US; Srivastava SK; Roy SC; More T
    Vet Microbiol; 1996 Oct; 52(3-4):301-11. PubMed ID: 8972056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Promotion of immunity of mice to Pasteurella multocida and hog cholera vaccine by pig interleukin-6 gene and CpG motifs.
    Zhao ZZ; Zhang HB; Chen Q; Su D; Xie Z; Wang YY; Yang Y; Wang ZZ; Li JL; Wu KY; Wang HN; Meng MJ; Gao R
    Comp Immunol Microbiol Infect Dis; 2009 May; 32(3):191-205. PubMed ID: 18279956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Formulation of an effective Pasteurella multocida vaccine for sheep.
    Cameron CM; Bester FJ
    Onderstepoort J Vet Res; 1984 Sep; 51(3):189-91. PubMed ID: 6533511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Construction of a ptfA chitosan nanoparticle DNA vaccine against Pasteurella multocida and the immune response in chickens.
    Gong Q; Kong LY; Niu MF; Qin CL; Yang Y; Li X; Ruan MD; Tian Y; Li ZL
    Vet J; 2018 Jan; 231():1-7. PubMed ID: 29429481
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunogenicity and protective efficacy of the recombinant
    Li Y; Xiao J; Chang YF; Zhang H; Teng Y; Lin W; Li H; Chen W; Zhang X; Xie Q
    Front Immunol; 2022; 13():985993. PubMed ID: 36275745
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Study of the immunological response of chickens to P. multocida bacterins with and without adjuvant by immunoblotting.
    Gunawardana GA; Frost AJ; Wilkie I
    Br Poult Sci; 2004 Apr; 45 Suppl 1():S40-1. PubMed ID: 15222362
    [No Abstract]   [Full Text] [Related]  

  • 74. [Characteristics and immunogenicity of the N-terminal and C-terminal recombinants of Pasteurella multocida toxin].
    Tang X; Wu B; Zhao Z; Deng Y; He H; He Q; Chen H
    Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):213-9. PubMed ID: 18438004
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibody reactions after aerogenous or subcutaneous immunization of pigs with Pasteurella multocida antigens.
    Müller G; Köhler H; Diller R; Erler W
    Vaccine; 2000 Nov; 19(7-8):751-7. PubMed ID: 11115696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo.
    Ghaffar A; Tariq A
    Gene; 2016 Apr; 580(1):58-66. PubMed ID: 26779825
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cross-protection and antigen expression by chicken embryo-grown Pasteurella multocida in chickens.
    Ibrahim RS; Sawada T; Shahata M; Ibrahim A
    J Comp Pathol; 2000 Nov; 123(4):278-84. PubMed ID: 11041997
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Field trial of a Pasteurella multocida extract vaccine in rabbits.
    Suckow MA; Haab RW; Miloscio LJ; Guilloud NB
    J Am Assoc Lab Anim Sci; 2008 Jan; 47(1):18-21. PubMed ID: 18210993
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sequence analysis of Pasteurella multocida major outer membrane protein (OmpH) and application of synthetic peptides in vaccination of chickens against homologous strain challenge.
    Luo Y; Zeng Q; Glisson JR; Jackwood MW; Cheng IH; Wang C
    Vaccine; 1999 Feb; 17(7-8):821-31. PubMed ID: 10067687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.